Sarepta Therapeutics (SRPT) PT Lowered to $205 at Needham
Needham analyst Gil Blum lowered ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
